It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Some features of ATS will be disabled while you continue to use an ad-blocker.
Cancer is one of the most difficult foes medical science has ever faced, but a controversial new idea might just show a way to victory. A group of scientists have evidence that cancer might be an evolutionary throwback to our most distant animal ancestor.
Astrobiologists Charles Lineweaver of the Australian National University and Paul Davies of Arizona State have proposed that cancerous cells are a so-called "living fossil", the last remnant of a crucial evolutionary juncture some 600 million years ago. It's been proposed before that cancer dates back to the beginning of multi-cellular animals, an evolutionary innovation that required cells to stop replicating whenever they wanted and start coordinating with the rest of the organism.
Cancer is what happens when these very ancient controls on cell replication break down, causing runaway cellular replication. But here's where Lineweaver and Davies take the idea a step further - they suggest cancer actually is our earliest animal ancestor. They suggest these organisms were the first to figure out some measure of control over cell replication, but they lacked more precise control over cell growth.
This hypothesis, they argue, fits known tumor behavior better than the view that all cancer cells act independently. They point to angiogenesis, in which cancer cells built blood vessel networks to bring nutrients into the tumor, which suggests cooperation amongst the cells. Indeed, the very act of metastasizing, in which cancerous cells move to other tissue areas, is hard to explain if all the cells are acting independently.
Well, Lineweaver and Davies suggest that, if cancer really is our evolutionary ancestor, then its genetic toolkit has been locked in place for 600 million years, and its repertoire of survival methods is infinitely more limited than that of, say, bacteria, which has the capacity to evolve resistance to practically any therapy.